NAM CROs & testing servicesconfirmed

PhenoVista Biosciences

High-content imaging and phenotypic assay services, including cell painting and neurotoxicity work.

Related deals

May 20, 2026
M&A
InSphero bought San Diego imaging and phenotypic assay provider PhenoVista to expand in the US.
Undisclosed
insphero.com(opens in new tab)

No related news yet.